TY  - ADVS
AU  - Swerdlow,Daniel I.
AU  - Holmes,Michael V.
TI  - Key drug discovery challenges in cardiovascular medicine
T2  - Genetics of cardiovascular disease : genetic interactions in a multifactorial disease,
PY  - 2014///
CY  - London
PB  - Henry Stewart Talks
KW  - Cardiovascular agents
KW  - Cardiovascular system
KW  - Diseases
KW  - Chemotherapy.
KW  - Drug development
KW  - Drugs
KW  - Research
KW  - Pharmacogenetics
KW  - Cardiovascular Agents
KW  - therapeutic use
KW  - Cardiovascular Diseases
KW  - drug therapy
KW  - Drug Discovery
KW  - methods
KW  - Precision Medicine
N1  - Animated audio-visual presentation with synchronized narration; Title from title frames; Contents: Conventional therapeutic targets in CVD -- Identifying new targets (GWAS and association analysis) -- Validating new targets (Mendelian randomisation; IL6R, CHD and tocilizumab; sPLA2 inhibition and CHD prevention) -- Avoiding adverse effects (The ILLUMINATE trial, Torcetrapib and blood pressure) -- Making better use of existing drugs (Pharmacogenetics of Clopidogrel and CYP2C19) -- New approaches & drug development; Access restricted to subscribers
UR  - https://hstalks.com/bs/2770/
UR  - https://hstalks.com/bs/p/379/
UR  - https://hstalks.com/bs/p/739/
ER  -